GlassScriptPhysician profile
Surit K Sharma
NPI 1376557140
$19,961.28
in general payments reported to CMS, 2019-2025
24 companies · $513 in 2025
The $513 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,506 · 2020: $283 · 2021: $1,042 · 2022: $1,073 · 2023: $13K · 2024: $2,413 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $9,200 · Food and Beverage: $3,995 · Travel and Lodging: $2,861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $9,199.98 |
| Food and Beverage | $3,994.87 |
| Travel and Lodging | $2,861.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,897.57 | 2019-2025 | Da Vinci Surgical System, Ion |
| Inspire Medical Systems, INC. | $1,683.90 | 2020-2024 | Inspire |
| Inari Medical, INC. | $1,470.43 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Ethicon INC. | $739.53 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $552.52 | 2021-2025 | Fasenra, Breztri, Tezspire |
| Glaxosmithkline, LLC. | $500.97 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Veran Medical Technologies, INC. | $498.50 | 2019-2020 | |
| Harmony Biosciences LLC | $307.02 | 2023-2025 | Wakix |
| Abiomed | $287.77 | 2023-2024 | Impella |
| Genzyme Corporation | $180.05 | 2021-2025 | |
| Zoll Respicardia, INC. | $155.44 | 2023 | Remede System |
| Siemens Medical Solutions USA, INC. | $138.49 | 2024 | |
| Edwards Lifesciences Corporation | $129.92 | 2023 | |
| Pulmonx Corporation | $109.25 | 2023 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Philips North America LLC | $56.64 | 2023-2024 | (Ak6) Vest Therapy |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $42.01 | 2023-2024 | Sunosi |
| Bayer Healthcare Pharmaceuticals INC. | $40.31 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $33.06 | 2023-2024 | Capvaxive, Pneumovax 23, Vaxneuvance |
| Lilly USA, LLC | $29.98 | 2025 | Zepbound |
| Regeneron Healthcare Solutions, INC. | $27.66 | 2024 | Dupixent |
| Pfizer INC. | $21.37 | 2024 | |
| Inogen, INC. | $21.30 | 2022 | |
| Boston Scientific Corporation | $19.32 | 2023 | Exalt Model D |
| Erbe USA INC | $18.27 | 2025 | Cryo 2 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Surit Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.